Read the Latest News

Repeated Injections of Botox into the Masseter Muscle... A Longitudinal Study

The authors of this study examined mandibular bone before and after subjects received Botox injections into each masseter muscle. These volunteers were healthy adults (22-48 years old), both male and female, who wanted injections to slim their faces.

Washington Post Article on TMD

The Washington Post recently featured an article on Temporomandibular Disorders. Below is an excerpt from that article and a link to the full story.

Partnering to Improve Chronic Pain Care

The National Institutes of Health (NIH) held three meetings this summer with the goal of developing the first public-private partnership (PPP) to develop safe and effective treatments for chronic pain, as well as new treatments for opioid addiction and overdose.

TMJ Patient RoundTable Project: Status Update

The TMJ Association is acting as the catalyst to develop the TMJ Patient RoundTable, a broad initiative to advance the interests of patients with temporomandibular disorders (TMD). It encompasses collaborations with all stakeholders and

Educational Brochures on Chronic Overlapping Pain Conditions

This brochure addresses what are Chronic Overlapping Pain Conditions (COPCs), how COPCs are diagnosed, the complexity of the chronic pain experience, and how to work with your health care provider to develop a treatment plan. It is available by postal ma

Repeated Injections of Botox into the Masseter Muscle... A Longitudinal Study

  • Oct 5, 2017

We thank Dr. Susan Herring for writing the following article summary.

Lee HJ, Kim SJ, Lee KJ, Yu HS, Baik HS. Repeated injections of botulinum toxin into the masseter muscle induce bony changes in human adults: A longitudinal study.   Korean J Orthod. 2017 Jul;47(4):222-228. 

The authors of this study examined mandibular bone before and after subjects received Botox injections into each masseter muscle. These volunteers were healthy adults (22-48 years old), both male and female, who wanted injections to slim their faces. (This happens because the Botox causes temporary muscle paralysis and the masseters undergo atrophy when they are not used.) The 20 subjects were randomized into two groups. One group received a single dose of Botox in each muscle while the second group got two doses. The second dose was given 4 months after the first. The bone scans were cone-beam computed tomography (CBCT), a 3-D technique with relatively low radiation. The after-Botox CBCT scan was performed 6 months after the initial injection. The scans were directed at the mandibular angle, where the masseter attaches. The TMJ region was not examined.

Even 6 months after a single injection, the masseter muscles were much smaller than before injection (loss of about 70 mm2). Predictably, the shrinkage was much greater for the two-injection group (loss of about 140 mm2).

The very limited amount of mandibular bone examined is only part of the masseter's attachment, and an unaffected muscle, the medial pterygoid, attaches to it as well. Therefore, it is surprising that the authors were able to document a loss of bone volume which was statistically significant in the 2-injection group. The loss was due to thinning of the bone, because the mandible as a whole did not become smaller. The authors refer to this finding as an "unwanted side effect" of multiple Botox injections of the masseter muscles.

This study was not ideal and leaves many questions unanswered. Sample size was small, there were no uninjected control subjects, differences between the groups at the start were not reported, the bone examination was very restricted, and it is unknown whether full restoration of muscle and bone would eventually have occurred.  

Nevertheless, it is the first prospective, randomized, longitudinal study of the effects of Botox on the human jaw. The finding of bone loss is consistent with the only other human Botox study on jaws, a cross-sectional examination of the condylar bone of TMJ disorder patients who did or did not receive masseter injections (Raphael et al. 2014). The paper by Lee et al. reinforces the idea that thinned and weakened jaw bones are likely side effects of Botox treatment.

 Raphael, K. G., A. Tadinada, J. M. Bradshaw, M. N. Janal, D. A. Sirois, K. C. Chan and A. G. Lurie (2014). Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study. J Oral Rehabil 41: 555-563.

Read the full article: https://synapse.koreamed.org/Synapse/Data/PDFData/1123KJOD/kjod-47-222.pdf

TMJ Disorders

Comments:

Login or Register to add Comment